Only a minority of left atrial appendages (LAAs) were found to be “entirely sealed” at 45-day cardiac computed tomography angiography (CCTA) scan with either the Amulet or new Watchman FLX LAA closure (LAAC) devices – the two most popular platforms on the market – in the SWISS-APERO trial.